AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22285123 — intervention group
Group type: COMPARATOR
Intervention: Control group (half saline solution as placebo with an equivalent infusion rate)
Number of subjects: 66
Study 22285123 — intervention group
Group type: EXPERIMENTAL
Intervention: GIK infusion
Number of subjects: 66
Study 22285123 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 66
Study 20299348 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% Aquafol
Number of subjects: 288
Study 20299348 — intervention group
Group type: COMPARATOR
Intervention: 1% Diprivan
Number of subjects: 288
Study 19023947 — intervention group
Group type: EXPERIMENTAL
Intervention: ProDisc C disc prosthesis
Number of subjects: 49
Study 19023947 — intervention group
Group type: COMPARATOR
Intervention: Anterior cervical discectomy and fusion (ACDF)
Number of subjects: 49
Study 15817582 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg daily
Number of subjects: 374
Study 15817582 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 374
Study 12036648 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 1%-lidocaine 2% (Group 1)
Number of subjects: 80
Study 12036648 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 0.5%-lidocaine 2% (Group 2)
Number of subjects: 80
Study 10438982 — intervention group
Group type: EXPERIMENTAL
Intervention: Blastocyst transfer (group B)
Number of subjects: 0
Study 10438982 — intervention group
Group type: COMPARATOR
Intervention: Day 3 ET (group A)
Number of subjects: 0
Study 7786704 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative intra-arterial fibrinolytic therapy (IIFT) with 250,000 IU of urokinase over 30 minutes
Number of subjects: 66
Study 7786704 — intervention group
Group type: COMPARATOR
Intervention: Mechanical thromboembolectomy alone
Number of subjects: 66
Study 2392793 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressurised metered dose inhaler (400 micrograms salbutamol)
Number of subjects: 9
Study 2392793 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry powder inhaler (400 micrograms salbutamol)
Number of subjects: 9
Study 2392793 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebuliser (400 micrograms salbutamol)
Number of subjects: 9
Study 507163 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% pilocarpine hydrochloride gel applied at bedtime
Number of subjects: 15
Study 507163 — intervention group
Group type: COMPARATOR
Intervention: 4% pilocarpine hydrochloride drops instilled four times daily
Number of subjects: 15
Study 30661908 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate-based foaming handwash
Number of subjects: 0
Study 30661908 — intervention group
Group type: EXPERIMENTAL
Intervention: Para-chloro-meta-xylenol foaming handwash
Number of subjects: 0
Study 30661908 — intervention group
Group type: COMPARATOR
Intervention: Bland soap (control)
Number of subjects: 0
Study 27858962 — intervention group
Group type: EXPERIMENTAL
Intervention: DBT skills training (n = 42)
Number of subjects: 84
Study 27858962 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (WL) (n = 42)
Number of subjects: 84
Study 27272805 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted surgery (RS)
Number of subjects: 109
Study 27272805 — intervention group
Group type: EXPERIMENTAL
Intervention: Open laparotomy (LT)
Number of subjects: 109
Study 27272805 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (LS)
Number of subjects: 109
Study 27272805 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 109
Study 24810873 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 0
Study 24810873 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 22904177 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole
Number of subjects: 31
Study 22904177 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 19403473 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal mupirocin ointment treatment and sodium hypochlorite (bleach) baths
Number of subjects: 31
Study 19403473 — intervention group
Group type: COMPARATOR
Intervention: Intranasal petrolatum ointment treatment and plain water baths (placebo)
Number of subjects: 31
Study 17502459 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanoparticular CoQ(10) (100 mg 3 times a day) for 3 months
Number of subjects: 131
Study 17502459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study 17181889 — intervention group
Group type: EXPERIMENTAL
Intervention: NaFeEDTA capsule containing 60 mg Fe once per week for IDs and IDE groups, three times per week for IDA group for nine consecutive weeks
Number of subjects: 1006
Study 17181889 — intervention group
Group type: EXPERIMENTAL
Intervention: NaFeEDTA capsule containing 60 mg Fe
Number of subjects: 1006
Study 11890101 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1,200 mg daily for 11 months)
Number of subjects: 778
Study 11890101 — intervention group
Group type: EXPERIMENTAL
Intervention: Decaffeinated green tea (DGT) (5 mg daily for 12 months)
Number of subjects: 778
Study 11890101 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for 11 months in calcium group and 12 months in DGT group)
Number of subjects: 778
Study 10434169 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilation at 10 breaths min‐1
Number of subjects: 0
Study 10434169 — intervention group
Group type: COMPARATOR
Intervention: Ventilation at 20 breaths min‐1
Number of subjects: 0
Study 7874570 — intervention group
Group type: EXPERIMENTAL
Intervention: nIFN‐alpha alone
Number of subjects: 16
Study 7874570 — intervention group
Group type: EXPERIMENTAL
Intervention: nIFN‐alpha/nIFN‐gamma
Number of subjects: 16
Study 7874570 — intervention group
Group type: COMPARATOR
Intervention: nIFN‐gamma alone
Number of subjects: 16
Study 7874570 — intervention group
Group type: EXPERIMENTAL
Intervention: nIFN‐alpha/nIFN‐gamma to lymph node metastases
Number of subjects: 16
Study 7874570 — intervention group
Group type: COMPARATOR
Intervention: nIFN‐alpha and nIFN‐gamma (systemic effects)
Number of subjects: 16
Study 1973969 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal hormone replacement therapy - continuous oestradiol 17‐beta 0.05 mg daily, with norethisterone acetate 0.25 mg daily for 14 of each 28 days
Number of subjects: 66
Study 1973969 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hormone replacement therapy - continuous conjugated equine oestrogens 0.625 mg daily, with dl‐norgestrel 0.15 mg daily for 12 of each 28 days
Number of subjects: 66
Study 1973969 — intervention group
Group type: COMPARATOR
Intervention: Untreated reference group
Number of subjects: 66
Study 1014769 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine‐N‐butyl‐bromide (HBB) sugar‐coated tablets (5 X 20 mg/daily)
Number of subjects: 37
Study 1014769 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 31512226 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-mild body wash with lipids
Number of subjects: 0
Study 31512226 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-mild body wash with lipids and zinc pyrithione
Number of subjects: 0
Study 31512226 — intervention group
Group type: COMPARATOR
Intervention: Mild synthetic bar
Number of subjects: 0
Study 31146788 — intervention group
Group type: EXPERIMENTAL
Intervention: BASIS
Number of subjects: 25
Study 31146788 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 25
Study 28548587 — intervention group
Group type: COMPARATOR
Intervention: TACE alone
Number of subjects: 44
Study 28548587 — intervention group
Group type: EXPERIMENTAL
Intervention: TACE combined with apatinib
Number of subjects: 44
Study 25479022 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril 3.5 mg/amlodipine 2.5 mg
Number of subjects: 1581
Study 25479022 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 5 mg
Number of subjects: 1581
Study 25479022 — intervention group
Group type: COMPARATOR
Intervention: Perindopril 3.5 mg
Number of subjects: 1581
Study 25479022 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 2.5 mg
Number of subjects: 1581
Study 23771796 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month lifestyle intervention (low-energy diet, physical activity)
Number of subjects: 100
Study 23771796 — intervention group
Group type: COMPARATOR
Intervention: Control group (70 non-obese children)
Number of subjects: 100
Study 21456305 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral iron supplement (200 mg ferrous sulfate) for two months
Number of subjects: 37
Study 21456305 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 37
Study 19639484 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief mindfulness instructions
Number of subjects: 0
Study 19639484 — intervention group
Group type: COMPARATOR
Intervention: Neutral condition
Number of subjects: 0
Study 15867047 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine infusions
Number of subjects: 898
Study 15867047 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine doses before intubation and at 25 to 72 hours
Number of subjects: 898
Study 15867047 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine therapy
Number of subjects: 898
Study 15867047 — intervention group
Group type: EXPERIMENTAL
Intervention: Preexisting hypotension
Number of subjects: 898
Study 10326317 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocking bed therapy
Number of subjects: 14
Study 10326317 — intervention group
Group type: COMPARATOR
Intervention: Standard bed
Number of subjects: 14
Study 7549814 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowering fat consumption to 20% of daily calories
Number of subjects: 100
Study 7549814 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 100
Study 1790545 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim and rifampin (TMP/R) 20 mg/kg/day
Number of subjects: 60
Study 1790545 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin (AMP) 150 mg/kg/day
Number of subjects: 60
Study 6891153 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol 2 micrograms/min
Number of subjects: 30
Study 31287890 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat hulls inclusion (3%)
Number of subjects: 0
Study 31287890 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-hatch egg weight (increased from 47.0 to 54.0 g)
Number of subjects: 0
Study 31287890 — intervention group
Group type: COMPARATOR
Intervention: Oat hulls inclusion (0%)
Number of subjects: 0
Study 28412230 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus a multi-modal oral health promotion program (Oral Health 4 Life) integrated within the quitline services
Number of subjects: 0
Study 28412230 — intervention group
Group type: COMPARATOR
Intervention: Standard quitline care
Number of subjects: 0
Study 27068858 — intervention group
Group type: EXPERIMENTAL
Intervention: Pazopanib plus best supportive care
Number of subjects: 81
Study 27068858 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care alone
Number of subjects: 81
Study 27068858 — intervention group
Group type: EXPERIMENTAL
Intervention: Pazopanib (after switch from best supportive care)
Number of subjects: 81
Study 25432467 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-assisted, home-based, remote monitored exercise-based cardiac rehabilitation (REMOTE) for 12 weeks
Number of subjects: 162
Study 25432467 — intervention group
Group type: COMPARATOR
Intervention: Standard supervised exercise-based cardiac rehabilitation for 8-12 weeks
Number of subjects: 162
Study 21708838 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.40 g/kg of alcohol
Number of subjects: 72
Study 21708838 — intervention group
Group type: COMPARATOR
Intervention: 0.00 g/kg (placebo)
Number of subjects: 72
Study 21708838 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.13 g/kg of alcohol
Number of subjects: 72
Study 19246474 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg of reboxetine (selective NE reuptake inhibitor)
Number of subjects: 18
Study 19246474 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 18085914 — intervention group
Group type: EXPERIMENTAL
Intervention: ST plus a maximum of $585 in contingent vouchers
Number of subjects: 74
Study 18085914 — intervention group
Group type: EXPERIMENTAL
Intervention: ST plus an expected average maximum of $300 in contingent prizes
Number of subjects: 74
Study 18085914 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (ST)
Number of subjects: 74
Study 14730663 — intervention group
Group type: EXPERIMENTAL
Intervention: Redesigned mask (RD)
Number of subjects: 20
Study 14730663 — intervention group
Group type: COMPARATOR
Intervention: Standard mask (SM)
Number of subjects: 20
Study 11488999 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-cisplatin
Number of subjects: 0
Study 11488999 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-carboplatin
Number of subjects: 0
Study 11488999 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel
Number of subjects: 0
Study 11488999 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Number of subjects: 0
Study 11488999 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedaplatin
Number of subjects: 0
Study 9428558 — intervention group
Group type: EXPERIMENTAL
Intervention: Head trauma group
Number of subjects: 24
Study 9428558 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 7851857 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 57
Study 7851857 — intervention group
Group type: COMPARATOR
Intervention: Open cholecystectomy
Number of subjects: 57
Study 29698742 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 117
Study 29698742 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training combined with protein and vitamin supplementation (RTS)
Number of subjects: 117
Study 29698742 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Training (CT)
Number of subjects: 117
Study 29121882 — intervention group
Group type: EXPERIMENTAL
Intervention: Balancing Everyday Life (BEL) program
Number of subjects: 226
Study 29121882 — intervention group
Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 226
Study 26209030 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic lavage
Number of subjects: 90
Study 26209030 — intervention group
Group type: COMPARATOR
Intervention: Sigmoidectomy
Number of subjects: 90
Study 23732247 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined individual and telephone counselling
Number of subjects: 600
Study 23732247 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual counselling
Number of subjects: 600
Study 23732247 — intervention group
Group type: COMPARATOR
Intervention: Telephone counselling
Number of subjects: 600
Study 21352881 — intervention group
Group type: EXPERIMENTAL
Intervention: Real tDCS (20-min session, anode over right prefrontal cortex, cathode over left prefrontal cortex)
Number of subjects: 19
Study 21352881 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 19
Study 21352881 — intervention group
Group type: EXPERIMENTAL
Intervention: Real tDCS
Number of subjects: 19
Study 19699148 — intervention group
Group type: COMPARATOR
Intervention: therapeutic CPAP (tCPAP) after one treatment night
Number of subjects: 52
Study 19699148 — intervention group
Group type: COMPARATOR
Intervention: 3 weeks of therapeutic CPAP (tCPAP)
Number of subjects: 52
Study 17378102 — intervention group
Group type: EXPERIMENTAL
Intervention: Planning conference where midwives reported new mothers to a doctor (intervention group)
Number of subjects: 1700
Study 17378102 — intervention group
Group type: COMPARATOR
Intervention: Standard care with routine consultation with the doctor (control group)
Number of subjects: 1700
Study 15499546 — intervention group
Group type: EXPERIMENTAL
Intervention: Infected breast milk cells (BMCs) per million cells
Number of subjects: 291
Study 15499546 — intervention group
Group type: EXPERIMENTAL
Intervention: Infected BMCs per milliliter
Number of subjects: 291
Study 15499546 — intervention group
Group type: EXPERIMENTAL
Intervention: Log10 increase in infected BMCs per milliliter
Number of subjects: 291
Study 11563806 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity (LI) group: 8 weeks of NRT and 1 advice and education session with a nurse practitioner (NP)
Number of subjects: 240
Study 11563806 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity (MI) group: NRT and 4 advice and education sessions with an NP
Number of subjects: 240
Study 11563806 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity (HI) group: NRT, 4 advice and education sessions, and 12 weeks of individualized cognitive-behavioral therapy
Number of subjects: 240
Study 9783558 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning light (approximately 6000 lux)
Number of subjects: 96
Study 9783558 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening light (approximately 6000 lux)
Number of subjects: 96
Study 9783558 — intervention group
Group type: COMPARATOR
Intervention: Morning placebo (sham negative-ion generators)
Number of subjects: 96
Study 7869999 — intervention group
Group type: EXPERIMENTAL
Intervention: Psyllium seeds (3 times 3.25 g daily)
Number of subjects: 30
Study 7869999 — intervention group
Group type: COMPARATOR
Intervention: Wheat bran (3 times 7 g daily)
Number of subjects: 30
Study 2971403 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate (Cl2MDP) 1.6 g/day
Number of subjects: 34
Study 2971403 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 30760190 — intervention group
Group type: EXPERIMENTAL
Intervention: Treg cells (CD4+CD25+FoxP3+)
Number of subjects: 92
Study 30760190 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated CD4+ and CD8+ T cells (CD38+ HLADR+)
Number of subjects: 92
Study 30760190 — intervention group
Group type: EXPERIMENTAL
Intervention: Treg cells
Number of subjects: 92
Study 29691562 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish (Group A)
Number of subjects: 600
Study 29691562 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride foam (Group B)
Number of subjects: 600
Study 29691562 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 600
Study 23649222 — intervention group
Group type: EXPERIMENTAL
Intervention: Content Acquisition Podcasts (CAPs) with explicit instructional methodology and keyword mnemonic strategy
Number of subjects: 279
Study 23649222 — intervention group
Group type: COMPARATOR
Intervention: Multimedia instruction without a specific theoretical design framework
Number of subjects: 279
Study 23649222 — intervention group
Group type: EXPERIMENTAL
Intervention: General education students receiving CAPs
Number of subjects: 279
Study 23649222 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction measure following multimedia instruction
Number of subjects: 279
Study 24075051 — intervention group
Group type: EXPERIMENTAL
Intervention: ASC-enriched fat grafts (20×10^6 cells per mL fat)
Number of subjects: 10
Study 24075051 — intervention group
Group type: COMPARATOR
Intervention: Control grafts (non-enriched fat grafts)
Number of subjects: 10
Study 21411557 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab (60 mg s.c. every 6 months)
Number of subjects: 7808
Study 19146606 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical antioxidant mixture containing vitamin C, ferulic acid, and phloretin
Number of subjects: 10
Study 19146606 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 10
Study 16831410 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy and selenium supplementation (400 mug/day for 6 months)
Number of subjects: 63
Study 16831410 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 63
Study 14636464 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine (3, 6, and 12 mg intravenous bolus doses)
Number of subjects: 122
Study 14636464 — intervention group
Group type: COMPARATOR
Intervention: Verapamil (5 mg or additional 5 mg intravenously)
Number of subjects: 122
Study 14636464 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine
Number of subjects: 122
Study 11112865 — intervention group
Group type: EXPERIMENTAL
Intervention: hcfHrp (BTA STAT(TM))
Number of subjects: 354
Study 8854770 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intraarterial chemotherapy with percutaneous hepatic venous isolation and charcoal hemoperfusion (HVI.CHP)
Number of subjects: 38
Study 8854770 — intervention group
Group type: COMPARATOR
Intervention: Conventional intraarterial chemotherapy (group S)
Number of subjects: 38
Study 8854770 — intervention group
Group type: COMPARATOR
Intervention: Transarterial embolization (TAE; group T)
Number of subjects: 38
Study 1615378 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nicardipine 0.03 mg/kg/h
Number of subjects: 52
Study 1615378 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nicardipine 0.08 mg/kg/h
Number of subjects: 52
Study 1615378 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nicardipine 0.11 mg/kg/h
Number of subjects: 52
Study 1615378 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nicardipine 0.15 mg/kg/h
Number of subjects: 52
Study 1615378 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nicardipine 90‐120 mg
Number of subjects: 52
Study 6380436 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer factor (1 ml extracted from the blood of normal individuals, administered starting 1 month postoperatively and at 3-month intervals)
Number of subjects: 63
Study 6380436 — intervention group
Group type: COMPARATOR
Intervention: Control group (no transfer factor treatment)
Number of subjects: 63
Study 6380436 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer factor
Number of subjects: 63
Study 6380436 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63
Study 31492430 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week weight loss program followed by 4-week weight stabilization
Number of subjects: 42
Study 31492430 — intervention group
Group type: COMPARATOR
Intervention: 16-week weight maintenance program
Number of subjects: 42
Study 29498885 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical excision of the macroscopically degenerated portion of the ECRB (n = 13)
Number of subjects: 26